A novel anticancer ribonucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine, enhances radiation-induced cell death in tumor cells.
about
Inhibition of HIF-1alpha by the anticancer drug TAS106 enhances X-ray-induced apoptosis in vitro and in vivo.Phase II study of TAS-106 in patients with platinum-failure recurrent or metastatic head and neck cancer and nasopharyngeal cancer.A nucleoside anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (TAS106), sensitizes cells to radiation by suppressing BRCA2 expression.
P2860
A novel anticancer ribonucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine, enhances radiation-induced cell death in tumor cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
A novel anticancer ribonucleos ...... ced cell death in tumor cells.
@en
type
label
A novel anticancer ribonucleos ...... ced cell death in tumor cells.
@en
prefLabel
A novel anticancer ribonucleos ...... ced cell death in tumor cells.
@en
P2093
P356
P1433
P1476
A novel anticancer ribonucleos ...... uced cell death in tumor cells
@en
P2093
Akiko Iwahara
Akira Matsuda
Ikuo Kashiwakura
Kenji Kitazato
Mikinori Kuwabara
Taketoshi Asanuma
Tohru Yamamori
Yasuhiro Kon
P304
P356
10.1667/RR3268
P577
2004-12-01T00:00:00Z